Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg
Clinical trial NCT03097211 · COMPLETED
Trial details
- NCT number
- NCT03097211
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-17
- Primary completion
- 2006-10-20
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.